4ocd

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (12:39, 1 March 2024) (edit) (undo)
 
(One intermediate revision not shown.)
Line 3: Line 3:
<StructureSection load='4ocd' size='340' side='right'caption='[[4ocd]], [[Resolution|resolution]] 2.10&Aring;' scene=''>
<StructureSection load='4ocd' size='340' side='right'caption='[[4ocd]], [[Resolution|resolution]] 2.10&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4ocd]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OCD OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4OCD FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4ocd]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4OCD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4OCD FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MWB:N1-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-N4-(4-((4,5-DIHYDRO-1H-IMIDAZOL-2-YL)AMINO)PHENYL)BENZENE-1,4-DIAMINE'>MWB</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1&#8491;</td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ocd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ocd OCA], [http://pdbe.org/4ocd PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4ocd RCSB], [http://www.ebi.ac.uk/pdbsum/4ocd PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4ocd ProSAT]</span></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MWB:N1-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-N4-(4-((4,5-DIHYDRO-1H-IMIDAZOL-2-YL)AMINO)PHENYL)BENZENE-1,4-DIAMINE'>MWB</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ocd FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ocd OCA], [https://pdbe.org/4ocd PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ocd RCSB], [https://www.ebi.ac.uk/pdbsum/4ocd PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ocd ProSAT]</span></td></tr>
</table>
</table>
-
<div style="background-color:#fffaf0;">
 
-
== Publication Abstract from PubMed ==
 
-
The DNA of several pathogens is very rich in AT base pairs. Typical examples include the malaria parasite Plasmodium falciparum and the causative agents of trichomoniasis and trypanosomiases. This fact has prompted studies of drugs which interact with the minor groove of DNA, some of which are used in medical practice. Previous studies have been performed almost exclusively with the AATT sequence. New features should be uncovered through the study of different DNA sequences. In this paper, the crystal structure of the complex of the DNA duplex d(AAAATTTT)2 with the dicationic drug 4,4'-bis(imidazolinylamino)diphenylamine (CD27) is presented. The drug binds to the minor groove of DNA as expected, but it shows two new features that have not previously been described: (i) the drugs protrude from the DNA and interact with neighbouring molecules, so that they may act as cross-linking agents, and (ii) the drugs completely cover the whole minor groove of DNA and displace bound water. Thus, they may prevent the access to DNA of proteins such as AT-hook proteins. These features are also expected for other minor-groove binding drugs when associated with all-AT DNA. These findings allow a better understanding of this family of compounds and will help in the development of new, more effective drugs. New data on the biological interaction of CD27 with the causative agent of trichomoniasis, Trichomonas vaginalis, are also reported.
 
- 
-
In and out of the minor groove: interaction of an AT-rich DNA with the drug CD27.,Acosta-Reyes FJ, Dardonville C, de Koning HP, Natto M, Subirana JA, Campos JL Acta Crystallogr D Biol Crystallogr. 2014 Jun;70(Pt 6):1614-21. doi:, 10.1107/S139900471400697X. Epub 2014 May 24. PMID:24914972<ref>PMID:24914972</ref>
 
- 
-
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 
-
</div>
 
-
<div class="pdbe-citations 4ocd" style="background-color:#fffaf0;"></div>
 
-
== References ==
 
-
<references/>
 
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Acosta-Reyes, F J]]
+
[[Category: Acosta-Reyes FJ]]
-
[[Category: Campos, J L]]
+
[[Category: Campos JL]]
-
[[Category: Dardonville, C]]
+
[[Category: Dardonville C]]
-
[[Category: Koning, H P.de]]
+
[[Category: Natto M]]
-
[[Category: Natto, M]]
+
[[Category: Subirana JA]]
-
[[Category: Subirana, J A]]
+
[[Category: De Koning HP]]
-
[[Category: All-at dna]]
+
-
[[Category: Dicationic drug]]
+
-
[[Category: Dna]]
+
-
[[Category: Dna minor groove binding drug]]
+
-
[[Category: Imidazoline drug]]
+

Current revision

In and Out the minor groove: Interaction of an AT rich-DNA with the CD27 drug

PDB ID 4ocd

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools